MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders
Leukemia Research and Treatment · 2012
DOI: 10.1155/2012/603830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Leukemia Research and Treatment, 2012. Verfasst von Yao Yuan und 4 weiteren Autor:innen. Beteiligte Einrichtung: New Jersey Medical School, Newark, NJ 08731, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Common blood disorders include hematopoietic cell malignancies or leukemias and plasma cell dyscrasia, all of which have associated microRNA abnormalities. In this paper, we discuss several leukemias including acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL) and identify altered microRNAs and their targets. Immune disorders with altered blood levels of antibodies include autoimmune disorders, such as systemic lupus erythematosus (SLE) with associated anti-self-autoantibodies and immunoglobulin A nephropathy (IgAN) also have related microRNA abnormalities. The alterations in microRNAs may serve as therapeutic targets in these blood disorders.
Autor:innen und Institutionen
- New Jersey Medical School, Newark, NJ 08731, USA.
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Yuan, Y., Kasar, S., Underbayev, C., Prakash, S., & Raveche, E. (2012). MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders. Leukemia Research and Treatment. https://doi.org/10.1155/2012/603830
Vancouver
Yuan Y, Kasar S, Underbayev C, Prakash S, Raveche E. MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders. Leukemia Research and Treatment. 2012. doi:10.1155/2012/603830
BibTeX
@article{Yuan2012,
author = {Yuan, Yao and Kasar, Siddha and Underbayev, Chingiz and Prakash, Sindhuri and Raveche, Elizabeth},
title = {MicroRNAs in Acute Myeloid Leukemia and Other Blood Disorders},
journal = {Leukemia Research and Treatment},
year = {2012},
doi = {10.1155/2012/603830}
}
EUVIMED